A role for parasite-induced PGE2 in IL-10-mediated host immunoregulation by skin stage schistosomula of Schistosoma mansoni

J Immunol. 2000 Oct 15;165(8):4567-74. doi: 10.4049/jimmunol.165.8.4567.

Abstract

Significant quantities of PGE(2) were produced by cercariae of Schistosoma mansoni following incubation with linoleic acid, a free fatty acid found on the surface of the skin. Cyclooxygenase (COX) 2 inhibitors failed to block this PGE(2) production, suggesting that a different biochemical pathway may be involved in the production of PGE(2) by the parasite. In addition, the parasites were also able to induce PGE(2) and IL-10 from human and mouse keratinocytes. Analysis of mouse skin during skin migratory phases of infection confirmed these in vitro observations. COX2 inhibitors blocked the parasite-induced PGE(2) and IL-10 from keratinocytes. Further analysis of the parasite secretions showed that the PGE(2)/IL-10-inducing effect was associated with a fraction <30 kDa molecular size. Addition of this fraction or parasite-stimulated keratinocyte culture supernatant to Con A-stimulated spleen cells resulted in the suppression of cell proliferation. This effect could be blocked by anti-IL-10 treatment. In sharp contrast, attenuation of the parasites with gamma-irradiation significantly abrogated their ability to induce PGE(2) or IL-10 from skin cells. Significance of IL-10 in host immunoregulation by skin stage schistosomula of S. mansoni was further confirmed by using IL-10-deficient mice. In these mice the normal subdued cutaneous reaction to the parasite was absent. Instead, a prominent cellular reaction occurred around the parasite, and there was considerable delay in parasitic migration through the skin. Thus these results suggest a key role for parasite-induced PGE(2) in IL-10-dependent down-regulation of host immune responses in the skin.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell-Free System / metabolism
  • Cell-Free System / parasitology
  • Cyclooxygenase Inhibitors / pharmacology
  • Dinoprostone / biosynthesis
  • Dinoprostone / metabolism
  • Dinoprostone / physiology*
  • Dose-Response Relationship, Immunologic
  • Growth Inhibitors / metabolism
  • Growth Inhibitors / physiology
  • Host-Parasite Interactions / immunology
  • Humans
  • Hypersensitivity, Delayed / immunology
  • Hypersensitivity, Delayed / prevention & control
  • Immunosuppressive Agents / immunology
  • Interleukin-10 / antagonists & inhibitors
  • Interleukin-10 / biosynthesis
  • Interleukin-10 / genetics
  • Interleukin-10 / physiology*
  • Keratinocytes / immunology
  • Keratinocytes / metabolism
  • Larva / immunology
  • Larva / metabolism
  • Lymphocyte Activation / immunology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • Schistosoma mansoni / enzymology
  • Schistosoma mansoni / growth & development*
  • Schistosoma mansoni / immunology*
  • Schistosoma mansoni / metabolism
  • Schistosomiasis mansoni / genetics
  • Schistosomiasis mansoni / immunology*
  • Schistosomiasis mansoni / metabolism
  • Schistosomiasis mansoni / parasitology*
  • Skin / immunology*
  • Skin / metabolism
  • Skin / parasitology*
  • Spleen / cytology
  • Spleen / immunology

Substances

  • Cyclooxygenase Inhibitors
  • Growth Inhibitors
  • Immunosuppressive Agents
  • Interleukin-10
  • Prostaglandin-Endoperoxide Synthases
  • Dinoprostone